Olanzapine reduces physical activity in rats exposed to activity-based anorexia: Possible implications for treatment of anorexia nervosa?

Biological Psychiatry

Volumn 58, Issue 8, 2005, Pages 651-657

  Hillebrand, Jacquelien J G ^a,b   Van Elburg, Annemarie A ^a,b   Kas, Martien J H ^a   Van Engeland, Herman ^a   Adan, Roger A H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Altrecht Rintveld Eating Disorders   (Netherlands)

Author keywords

Anorexia; Antipsychotic; Food restriction; Hyperactivity; Running wheel

Indexed keywords

LEPTIN; OLANZAPINE;

ADOLESCENT; ADULT; ANIMAL MODEL; ANOREXIA NERVOSA; ARTICLE; BLOOD LEVEL; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHERMIA; MALE; NONHUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RAT; STARVATION; TREADMILL;

ADIPOSE TISSUE; ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANOREXIA; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; BENZODIAZEPINES; BODY TEMPERATURE; BODY WEIGHT; CORTICOSTERONE; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; EATING; FEMALE; HUMANS; MALE; MOTOR ACTIVITY; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; RUNNING; TIME FACTORS;

EID: 27644471945     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2005.04.008     Document Type: Article

References (56)

1. D.B. Allison, D.E. Casey Antipsychotic-induced weight gain A review of the literature J Clin Psychiatry 62 suppl 7 2001 22 31
2. M. Altemus, J.R. Glowa, E. Galliven, Y.M. Leong, D.L. Murphy Effects of serotonergic agents on food-restriction-induced hyperactivity Pharmacol Biochem Behav 53 1996 123 131
3. T. Ando, G. Komaki, M. Karibe, N. Kawamura, S. Hara, M. Takii 5-HT2A promoter polymorphism is not associated with anorexia nervosa in Japanese patients Psychiatr Genet 11 2001 157 160
4. M. Aravagiri, D. Ames, W.C. Wirshing, S.R. Marder Plasma level monitoring of olanzapine in patients with schizophrenia Determination by high-performance liquid chromatography with electrochemical detection Ther Drug Monit 19 1997 307 313
5. N.C. Barbarich, C.W. McConaha, J. Gaskill, M. La Via, G.K. Frank, S. Achenbach An open trial of olanzapine in anorexia nervosa J Clin Psychiatry 65 2004 1480 1482
6. A. Boachie, G.S. Goldfield, W. Spettigue Olanzapine use as an adjunctive treatment for hospitalized children with anorexia nervosa Case reports Int J Eat Disord 33 2003 98 103
7. T.D. Brewerton, D.C. Jimerson Studies of serotonin function in anorexia nervosa Psychiatry Res 62 1996 31 42
8. V.R. Burden, B.D. White, R.G. Dean, R.J. Martin Activity of the hypothalamic-pituitary-adrenal axis is elevated in rats with activity-based anorexia J Nutr 123 1993 1217 1225
9. F.P. Bymaster, S.K. Hemrick-Luecke, K.W. Perry, R.W. Fuller Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, alpha 1-adrenergic and muscarinic receptors in vivo in rats Psychopharmacology (Berl) 124 1996 87 94
10. F.P. Bymaster, K. Rasmussen, D.O. Calligaro, D.L. Nelson, N.W. DeLapp, D.T. Wong In vitro and in vivo biochemistry of olanzapine A novel, atypical antipsychotic drug J Clin Psychiatry 58 suppl 10 1997 28 36
11. R.C. Casper, D.A. Schoeller, R. Kushner, J. Hnilicka, S.T. Gold Total daily energy expenditure and activity level in anorexia nervosa Am J Clin Nutr 53 1991 1143 1150
12. P.G. Clifton, M.D. Lee, C.T. Dourish Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist and d-fenfluramine on feeding patterns in the rat Psychopharmacology (Berl) 152 2000 256 267
13. D.A. Collier, M.J. Arranz, T. Li, D. Mupita, N. Brown, J. Treasure Association between 5-HT2A gene promoter polymorphism and anorexia nervosa Lancet 350 1997 412
14. P.J. Currie, D.V. Coscina Metergoline potentiates natural feeding and antagonizes the anorectic action of medical hypothalamic 5-hydroxytryptamine Pharmacol Biochem Behav 53 1996 1023 1028
15. P. Dally, W. Sargant Treatment and outcome of anorexia nervosa BMJ 2 1966 793 795
16. C. Davis Eating disorders and hyperactivity A psychobiological perspective Can J Psychiatry 42 1997 168 175
17. D.D. Di Bella, M. Catalano, M.C. Cavallini, C. Riboldi, L. Bellodi Serotonin transporter linked polymorphic region in anorexia nervosa and bulimia nervosa Mol Psychiatry 5 2000 233 234
18. C. Exner, J. Hebebrand, H. Remschmidt, C. Wewetzer, A. Ziegler, S. Herpertz Leptin suppresses semi-starvation induced hyperactivity in rats Implications for anorexia nervosa Mol Psychiatry 5 2000 476 481
19. K. Fukagawa, T. Sakata, T. Shiraishi, H. Yoshimatsu, K. Fujimoto, K. Ookuma Neuronal histamine modulates feeding behavior through H1-receptor in rat hypothalamus Am J Physiol 256 1989 R605 R611
20. P. Gorwood, J. Ades, L. Bellodi, E. Cellini, D.A. Collier, D. Di Bella The 5-HT(2A) -1438G/A polymorphism in anorexia nervosa A combined analysis of 316 trios from six European centres Mol Psychiatry 7 2002 90 94
21. J. Hebebrand, W.F. Blum, N. Barth, H. Coners, P. Englaro, A. Juul Leptin levels in patients with anorexia nervosa are reduced in the acute stage and elevated upon short-term weight restoration Mol Psychiatry 2 1997 330 334
22. L.K. Heisler, M.A. Cowley, L.H. Tecott, W. Fan, M.J. Low, J.L. Smart Activation of central melanocortin pathways by fenfluramine Science 297 2002 609 611
23. A. Hinney, N. Barth, A. Ziegler, S. von Prittwitz, A. Hamann, K. Hennighausen Serotonin transporter gene-linked polymorphic region Allele distributions in relationship to body weight and in anorexia nervosa Life Sci 61 1997 L-303
24. L. Hoffman, K. Halmi Psychopharmacology in the treatment of anorexia nervosa and bulimia nervosa Psychiatr Clin North Am 16 1993 767 778
25. X. Hu, O. Giotakis, T. Li, A. Karwautz, J. Treasure, D.A. Collier Association of the 5-HT2c gene with susceptibility and minimum body mass index in anorexia nervosa Neuroreport 14 2003 781 783
26. C. Johnson, M. Stuckey, J. Mitchell Psychopharmacological treatment of anorexia nervosa and bulimia. Review and synthesis J Nerv Ment Dis 171 1983 524 534
27. S. Kapur, S.C. VanderSpek, B.A. Brownlee, J.N. Nobrega Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition A suggested solution based on in vivo occupancy J Pharmacol Exp Ther 305 2003 625 631
28. M.J. Kas, G. van Dijk, A.J. Scheurink, R.A. Adan Agouti-related protein prevents self-starvation Mol Psychiatry 8 2003 235 240
29. W. Kaye, K. Gendall, M. Strober Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa Biol Psychiatry 44 1998 825 838
30. W.H. Kaye, H.E. Gwirtsman, D.T. George, M.H. Ebert Altered serotonin activity in anorexia nervosa after long-term weight restoration. Does elevated cerebrospinal fluid 5-hydroxyindoleacetic acid level correlate with rigid and obsessive behavior? Arch Gen Psychiatry 48 1991 556 562
31. W.H. Kaye, T. Nagata, T.E. Weltzin, L.K. Hsu, M.S. Sokol, C. McConaha Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa Biol Psychiatry 49 2001 644 652
32. D.A. Klein, A.S. Bennett, J. Schebendach, R.W. Foltin, M.J. Devlin, B.T. Walsh Exercise "addiction" in anorexia nervosa Model development and pilot data CNS Spectr 9 2004 531 537
33. L. Kron, J.L. Katz, G. Gorzynski, H. Weiner Hyperactivity in anorexia nervosa A fundamental clinical feature Compr Psychiatry 19 1978 433 440
34. V. Lozeva, A. Valjakka, A. Lecklin, H. Olkkonen, M. Hippelainen, M. Itkonen Effects of the histamine H(1) receptor blocker, pyrilamine, on spontaneous locomotor activity of rats with long-term portacaval anastomosis Hepatology 31 2000 336 344
35. A. Malina, J. Gaskill, C. McConaha, G.K. Frank, M. LaVia, L. Scholar Olanzapine treatment of anorexia nervosa a retrospective study Int J Eat Disord 33 2003 234 237
36. C. Mehler, C. Wewetzer, U. Schulze, A. Warnke, F. Theisen, R.W. Dittmann Olanzapine in children and adolescents with chronic anorexia nervosa. A study of five cases Eur Child Adolesc Psychiatry 10 2001 151 157
37. N.A. Moore Olanzapine preclinical pharmacology and recent findings Br J Psychiatry Suppl 1999 41 44
38. B. Nacmias, V. Ricca, A. Tedde, B. Mezzani, C.M. Rotella, S. Sorbi 5-HT2A receptor gene polymorphisms in anorexia nervosa and bulimia nervosa Neurosci Lett 277 1999 134 136
39. M.J. Nijsen, G. Croiset, R. Stam, A. Bruijnzeel, M. Diamant, D. de Wied The role of the CRH type 1 receptor in autonomic responses to corticotropin-releasing hormone in the rat Neuropsychopharmacology 22 2000 388 399
40. N. Nishiguchi, S. Matsushita, K. Suzuki, M. Murayama, O. Shirakawa, S. Higuchi Association between 5HT2A receptor gene promoter region polymorphism and eating disorders in Japanese patients Biol Psychiatry 50 2001 123 128
41. S. Oerther, S. Ahlenius Atypical antipsychotics and dopamine D(1) receptor agonism An in vivo experimental study using core temperature measurements in the rat J Pharmacol Exp Ther 292 2000 731 736
42. K.J. Pederson, J.L. Roerig, J.E. Mitchell Towards the pharmacotherapy of eating disorders Expert Opin Pharmacother 4 2003 1659 1678
43. K.M. Pirke, A. Broocks, T. Wilckens, R. Marquard, U. Schweiger Starvation-induced hyperactivity in the rat The role of endocrine and neurotransmitter changes Neurosci Biobehav Rev 17 1993 287 294
44. B. Pouzet, T. Mow, M. Kreilgaard, S. Velschow Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in human Pharmacol Biochem Behav 75 2003 133 140
45. P.S. Powers, C.A. Santana, Y.S. Bannon Olanzapine in the treatment of anorexia nervosa An open label trial Int J Eat Disord 32 2002 146 154
46. E.P. Prinssen, W. Koek, M.S. Kleven The effects of antipsychotics with 5-HT(2C) receptor affinity in behavioral assays selective for 5-HT(2C) receptor antagonist properties of compounds Eur J Pharmacol 388 2000 57 67
47. A. Routtenberg, A.W. Kuznesof Self-starvation of rats living in activity wheels on a restricted feeding schedule J Comp Physiol Psychol 64 1967 414 421
48. A. Schotte, P.F. Janssen, W. Gommeren, W.H. Luyten, P. Van Gompel, A.S. Lesage Risperidone compared with new and reference antipsychotic drugs In vitro and in vivo receptor binding Psychopharmacology (Berl) 124 1996 57 73
49. P.F. Sullivan Mortality in anorexia nervosa Am J Psychiatry 152 1995 1073 1074
50. Z. Thornton-Jones, J.C. Neill, G.P. Reynolds The atypical antipsychotic olanzapine enhances ingestive behaviour in the rat A preliminary study J Psychopharmacol 16 2002 35 37
51. W. Vandereycken Neuroleptics in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled study with sulpiride Br J Psychiatry 144 1984 288 292
52. W. Vandereycken, R. Pierloot Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled cross-over study Acta Psychiatr Scand 66 1982 445 450
53. S.P. Vickers, K.R. Benwell, R.H. Porter, M.J. Bickerdike, G.A. Kennett, C.T. Dourish Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats Br J Pharmacol 130 2000 1305 1314
54. S.P. Vickers, P.G. Clifton, C.T. Dourish, L.H. Tecott Reduced satiating effect of d-fenfluramine in serotonin 5-HT(2C) receptor mutant mice Psychopharmacology (Berl) 143 1999 309 314
55. B.T. Walsh, M.J. Devlin Eating disorders Progress and problems Science 280 1998 1387 1390
56. L. Westberg, J. Bah, M. Rastam, C. Gillberg, E. Wentz, J. Melke Association between a polymorphism of the 5-HT2C receptor and weight loss in teenage girls Neuropsychopharmacology 26 2002 789 793